1. JAK/STAT Signaling Protein Tyrosine Kinase/RTK Autophagy Apoptosis Metabolic Enzyme/Protease
  2. EGFR Autophagy Apoptosis Endogenous Metabolite
  3. Genistein

ゲニステイン  (Synonyms: Genistein; NPI 031L)

製品番号: HY-14596 純度: 99.82%
COA 取扱説明書 Technical Support

Genistein, a soy isoflavone, is a multiple tyrosine kinases (e.g., EGFR) inhibitor which acts as a chemotherapeutic agent against different types of cancer, mainly by altering apoptosis, the cell cycle, and angiogenesis and inhibiting metastasis.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 446-72-0

容量 価格(税別) 在庫状況 数量
>無料サンプル (0.1 - 0.2 mg)   今すぐ申し込む  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 72 在庫あり
Solution
10 mM * 1 mL in DMSO USD 72 在庫あり
Solid
100 mg $66 在庫あり
500 mg $117 在庫あり
1 g $170 在庫あり
5 g   お問い合わせ  
10 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 88 publication(s) in Google Scholar

Other Forms of Genistein:

Top Publications Citing Use of Products

顧客検証

Flow Cytometry

    Genistein purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2025 Oct 21;10(1):349.  [Abstract]

    Analysis of the cellular uptake pathways of OVA PCD. Ethamilamiline (EIPA), genistein (GEN, 200 μM), and chlorpromazine (CPZ), pretreated for 4 h, subsequently incubated with FITC-labeled OVA PCD for 12 h were used to inhibit macropinocytosis, caveolin-mediated endocytosis, and clathrin-mediated endocytosis, respectively (n = 5).

    Genistein purchased from MedChemExpress. Usage Cited in: Nat Immunol. 2025 Apr 11.  [Abstract]

    Flow cytometry analysis of FDG MFI of neutrophils treated with dimethyl sulfoxide (DMSO) or different metabolites; the neutrophil FDG MFI ratio of metabolites relative to DMSO was calculated (n = 3).

    Genistein purchased from MedChemExpress. Usage Cited in: Nat Biomed Eng. 2024 Nov;8(11):1469-1482.  [Abstract]

    Cellular uptake pathway of different formulations. Cells were pretreated 2h with methyl-β-cyclodextrin (MCD), genistein (Gen, 200 µM), amiloride (AMI) or chlorpromazine (CPZ), to block lipid raft, caveolae-mediated endocytosis, micropinocytosis and clathrin-mediated endocytosis, respectively.

    Genistein purchased from MedChemExpress. Usage Cited in: Bioact Mater. 2021 Jan 14;6(7):2158-2172.

    Transcytosis efficiency of FITC-labelled aPD/IND@MON-IgG and aPD/IND@MON-aANN at 30 min and 60 min in the transcytosis model pretreated with or without 200 μM genistein (endocytic pathway inhibitor) or 20 μM EXO1 (exocytic pathway inhibitor) for 2h.

    Genistein purchased from MedChemExpress. Usage Cited in: Nat Nanotechnol. 2020 Dec;15(12):1043-1052.  [Abstract]

    Flow cytometry measured the FITC MFI of CD11c+ BMDCs for BMDCs incubated with F7-PEI/FITC-OVA or F13-PEI/FITC-OVA, w/wo adding indicated endocytosis inhibitors (n = 3). BMDCs were incubated with genistein (700μM) for 30min before the addition of F7-PEI/OVA-FITC or F13-PEI/OVA-FITCNPs.

    EGFR アイソフォーム固有の製品をすべて表示:

    Endogenous Metabolite アイソフォーム固有の製品をすべて表示:

    • 生物活性

    • プロトコル

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Genistein, a soy isoflavone, is a multiple tyrosine kinases (e.g., EGFR) inhibitor which acts as a chemotherapeutic agent against different types of cancer, mainly by altering apoptosis, the cell cycle, and angiogenesis and inhibiting metastasis.

    IC50 & Target[1]

    EGFR

    0.6 μM (IC50, Cell Assay)

    Cellular Effect
    Cell Line Type Value Description References
    A-431 EC50
    108 3
    Compound: 2
    Antiproliferative activity against human A431 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human A431 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    A-431 EC50
    278 3
    Compound: 2
    Antiproliferative activity against human A431 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human A431 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    A-431 EC50
    108 3
    Compound: 2
    Antiproliferative activity against human A431 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human A431 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    A-431 EC50
    278 3
    Compound: 2
    Antiproliferative activity against human A431 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human A431 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    A-431 IC50
    0.1 6
    Compound: 3
    Inhibition of EGFR in human A431 cells
    Inhibition of EGFR in human A431 cells
    [PMID: 1479375]
    A549 IC50
    43.09 3
    Compound: 1
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    A549 IC50
    64 3
    Compound: Gen
    Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    A-431 IC50
    0.7 6
    Compound: 3
    Inhibition of EGFR in human A431 cells
    Inhibition of EGFR in human A431 cells
    [PMID: 1479375]
    AGS IC50
    41.67 3
    Compound: 1
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    [PMID: 21129977]
    A549 IC50
    43.09 3
    Compound: 1
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    A-431 EC50
    108 3
    Compound: 2
    Antiproliferative activity against human A431 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human A431 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    A549 IC50
    64 3
    Compound: Gen
    Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    B16-F10 IC50
    79.21 3
    Compound: 3
    Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
    Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
    [PMID: 27720556]
    A-431 EC50
    278 3
    Compound: 2
    Antiproliferative activity against human A431 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human A431 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    BALB/3T3 IC50
    183.9 3
    Compound: 9
    Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
    Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
    [PMID: 10096863]
    AGS IC50
    41.67 3
    Compound: 1
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    [PMID: 21129977]
    A-431 IC50
    1 x 10-1 6
    Compound: 3
    Inhibition of EGFR in human A431 cells
    Inhibition of EGFR in human A431 cells
    [PMID: 1479375]
    Balb/MK IC50
    9.1 3
    Compound: Genistein
    Tested for antiproliferative activity using mouse epidermal keratinocytes cell line (BALB/MK)
    Tested for antiproliferative activity using mouse epidermal keratinocytes cell line (BALB/MK)
    [PMID: 7608909]
    A-431 IC50
    7 x 10-1 6
    Compound: 3
    Inhibition of EGFR in human A431 cells
    Inhibition of EGFR in human A431 cells
    [PMID: 1479375]
    BJ EC50
    > 86.2069 3
    Compound: 2
    Antiproliferative activity against human BJ cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human BJ cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    B16-F10 IC50
    79.21 3
    Compound: 3
    Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
    Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
    [PMID: 27720556]
    BT-20 IC50
    46 3
    Compound: Genistein
    Antiproliferative activity against human BT20 cell line by MTT assay
    Antiproliferative activity against human BT20 cell line by MTT assay
    [PMID: 16789737]
    BALB/3T3 IC50
    183.9 3
    Compound: 9
    Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
    Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
    [PMID: 10096863]
    BXPC-3 IC50
    30 3
    Compound: Genistein
    Antiproliferative activity against human BxPC3 cell line by MTT assay
    Antiproliferative activity against human BxPC3 cell line by MTT assay
    [PMID: 16789737]
    Balb/MK IC50
    9.1 3
    Compound: Genistein
    Tested for antiproliferative activity using mouse epidermal keratinocytes cell line (BALB/MK)
    Tested for antiproliferative activity using mouse epidermal keratinocytes cell line (BALB/MK)
    [PMID: 7608909]
    A549 IC50
    43.09 3
    Compound: 1
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    Cytotoxicity against human A549 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    BXPC-3 IC50
    79 3
    Compound: Gen
    Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    BJ EC50
    >86.2069 3
    Compound: 2
    Antiproliferative activity against human BJ cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human BJ cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    A549 IC50
    64 3
    Compound: Gen
    Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    AGS IC50
    41.67 3
    Compound: 1
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    Cytotoxicity against human AGS cells after 72 hrs by MTT assay
    [PMID: 21129977]
    BT-20 IC50
    46 3
    Compound: Genistein
    Antiproliferative activity against human BT20 cell line by MTT assay
    Antiproliferative activity against human BT20 cell line by MTT assay
    [PMID: 16789737]
    C8166 EC50
    13.9 6
    Compound: 7
    Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis
    Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis
    [PMID: 24794743]
    C8166 CC50
    36.2 6
    Compound: 7
    Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
    Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
    [PMID: 24794743]
    ANN-1 IC50
    8 3
    Compound: (1a) genistein
    Cytotoxic effect on v-abl transformed murine ANN-1 cells
    Cytotoxic effect on v-abl transformed murine ANN-1 cells
    [PMID: 8201603]
    Caco-2 IC50
    > 100 3
    Compound: 1
    Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay
    Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    B16-F10 IC50
    79.21 3
    Compound: 3
    Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
    Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
    [PMID: 27720556]
    BXPC-3 IC50
    30 3
    Compound: Genistein
    Antiproliferative activity against human BxPC3 cell line by MTT assay
    Antiproliferative activity against human BxPC3 cell line by MTT assay
    [PMID: 16789737]
    COLO 201 IC50
    73 3
    Compound: Gen
    Cytotoxicity against human COLO201 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human COLO201 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    BXPC-3 IC50
    79 3
    Compound: Gen
    Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    COLO357 IC50
    50 3
    Compound: Genistein
    Antiproliferative activity against human COLO357 cell line by MTT assay
    Antiproliferative activity against human COLO357 cell line by MTT assay
    [PMID: 16789737]
    C8166 CC50
    36.2 6
    Compound: 7
    Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
    Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
    [PMID: 24794743]
    BALB/3T3 IC50
    183.9 3
    Compound: 9
    Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
    Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay
    [PMID: 10096863]
    DLD-1 IC50
    50 3
    Compound: 51
    Antiproliferative activity against human DLD-1 cells assessed as reduction in cell viability by MTS assay
    Antiproliferative activity against human DLD-1 cells assessed as reduction in cell viability by MTS assay
    [PMID: 33445154]
    C8166 EC50
    13.9 6
    Compound: 7
    Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis
    Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis
    [PMID: 24794743]
    BJ EC50
    > 86.2069 3
    Compound: 2
    Antiproliferative activity against human BJ cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human BJ cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    DU-145 IC50
    > 100 3
    Compound: Genistein
    Cytotoxicity against human androgen-independent DU145 cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    Cytotoxicity against human androgen-independent DU145 cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    [PMID: 26341135]
    Caco-2 IC50
    >100 3
    Compound: 1
    Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay
    Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    BT-20 IC50
    46 3
    Compound: Genistein
    Antiproliferative activity against human BT20 cell line by MTT assay
    Antiproliferative activity against human BT20 cell line by MTT assay
    [PMID: 16789737]
    DU-145 ED50
    2.39 6
    Compound: 5
    Cytotoxicity against human DU145 cells after 6 days by MTT assay
    Cytotoxicity against human DU145 cells after 6 days by MTT assay
    [PMID: 12088420]
    BV-2 IC50
    28.4 3
    Compound: 6
    Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production
    Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production
    [PMID: 29482940]
    DU-145 IC50
    47.29 3
    Compound: 1
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    COLO 201 IC50
    73 3
    Compound: Gen
    Cytotoxicity against human COLO201 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human COLO201 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    HCT-116 IC50
    34.9 3
    Compound: 1
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    COLO357 IC50
    50 3
    Compound: Genistein
    Antiproliferative activity against human COLO357 cell line by MTT assay
    Antiproliferative activity against human COLO357 cell line by MTT assay
    [PMID: 16789737]
    HEK293 IC50
    > 100 3
    Compound: Genistein
    Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    BXPC-3 IC50
    30 3
    Compound: Genistein
    Antiproliferative activity against human BxPC3 cell line by MTT assay
    Antiproliferative activity against human BxPC3 cell line by MTT assay
    [PMID: 16789737]
    BXPC-3 IC50
    79 3
    Compound: Gen
    Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    HEK293 IC50
    22 3
    Compound: genistein
    Antagonist activity at human recombinant LXRbeta expressed in HEK293 cells by luciferase reporter gene assay
    Antagonist activity at human recombinant LXRbeta expressed in HEK293 cells by luciferase reporter gene assay
    [PMID: 18343126]
    DLD-1 IC50
    50 3
    Compound: 51
    Antiproliferative activity against human DLD-1 cells assessed as reduction in cell viability by MTS assay
    Antiproliferative activity against human DLD-1 cells assessed as reduction in cell viability by MTS assay
    [PMID: 33445154]
    DU-145 ED50
    2.39 6
    Compound: 5
    Cytotoxicity against human DU145 cells after 6 days by MTT assay
    Cytotoxicity against human DU145 cells after 6 days by MTT assay
    [PMID: 12088420]
    HEK293 IC50
    25.12 3
    Compound: Genistein
    Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    Balb/MK IC50
    9.1 3
    Compound: Genistein
    Tested for antiproliferative activity using mouse epidermal keratinocytes cell line (BALB/MK)
    Tested for antiproliferative activity using mouse epidermal keratinocytes cell line (BALB/MK)
    [PMID: 7608909]
    HEK293 IC50
    31 3
    Compound: genistein
    Antagonist activity at human recombinant LXRalpha expressed in HEK293 cells by luciferase reporter gene assay
    Antagonist activity at human recombinant LXRalpha expressed in HEK293 cells by luciferase reporter gene assay
    [PMID: 18343126]
    DU-145 IC50
    >100 3
    Compound: Genistein
    Cytotoxicity against human androgen-independent DU145 cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    Cytotoxicity against human androgen-independent DU145 cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    [PMID: 26341135]
    C8166 CC50
    36.2 6
    Compound: 7
    Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
    Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
    [PMID: 24794743]
    HEK293 IC50
    58.18 3
    Compound: Genistein
    Inhibition of Fyn (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of Fyn (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    C8166 EC50
    13.9 6
    Compound: 7
    Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis
    Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis
    [PMID: 24794743]
    DU-145 IC50
    47.29 3
    Compound: 1
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    HCT-116 IC50
    34.9 3
    Compound: 1
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    HEK293 IC50
    67.99 3
    Compound: Genistein
    Inhibition of Bmx (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of Bmx (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    HEK293 IC50
    31 3
    Compound: genistein
    Antagonist activity at human recombinant LXRalpha expressed in HEK293 cells by luciferase reporter gene assay
    Antagonist activity at human recombinant LXRalpha expressed in HEK293 cells by luciferase reporter gene assay
    [PMID: 18343126]
    HepG2 IC50
    > 100 3
    Compound: Genistein
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    [PMID: 26896708]
    HepG2 EC50
    67.6945 3
    Compound: 2
    Antiproliferative activity against human HepG2 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human HepG2 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    HEK293 IC50
    22 3
    Compound: genistein
    Antagonist activity at human recombinant LXRbeta expressed in HEK293 cells by luciferase reporter gene assay
    Antagonist activity at human recombinant LXRbeta expressed in HEK293 cells by luciferase reporter gene assay
    [PMID: 18343126]
    HEK293 IC50
    67.99 3
    Compound: Genistein
    Inhibition of Bmx (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of Bmx (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    Hs-578T ED50
    3.5 6
    Compound: 5
    Cytotoxicity against human Hs 578T cells after 6 days by MTT assay
    Cytotoxicity against human Hs 578T cells after 6 days by MTT assay
    [PMID: 12088420]
    HEK293 IC50
    25.12 3
    Compound: Genistein
    Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    Hs746T ED50
    5.82 6
    Compound: 5
    Cytotoxicity against human Hs 746T cells after 6 days by MTT assay
    Cytotoxicity against human Hs 746T cells after 6 days by MTT assay
    [PMID: 12088420]
    HEK293 IC50
    58.18 3
    Compound: Genistein
    Inhibition of Fyn (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of Fyn (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    HT-29 IC50
    50 3
    Compound: Gen
    Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    HT-29 IC50
    52.78 3
    Compound: 1
    Cytotoxicity against human HT-29 cells after 72 hrs by SRB assay
    Cytotoxicity against human HT-29 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    HEK293 IC50
    2.21 3
    Compound: 21
    Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
    Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
    [PMID: 18533708]
    COLO 201 IC50
    73 3
    Compound: Gen
    Cytotoxicity against human COLO201 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human COLO201 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    Huh-7 CC50
    > 50 3
    Compound: 23
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    [PMID: 22445328]
    HEK293 IC50
    16.5 3
    Compound: 21
    Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
    Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
    [PMID: 18533708]
    COLO357 IC50
    50 3
    Compound: Genistein
    Antiproliferative activity against human COLO357 cell line by MTT assay
    Antiproliferative activity against human COLO357 cell line by MTT assay
    [PMID: 16789737]
    HEK293 IC50
    >100 3
    Compound: Genistein
    Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    Huh-7 EC50
    14.4 3
    Compound: 23
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    [PMID: 22445328]
    Huh-7 IC50
    20 3
    Compound: Genistein
    Antiplasmodial activity against liver sporozoite stage of Plasmodium berghei ANKA expressing GFP infected in human HuH7 cells assessed as inhibition of parasite development after 24 hrs by qRT-PCR analysis
    Antiplasmodial activity against liver sporozoite stage of Plasmodium berghei ANKA expressing GFP infected in human HuH7 cells assessed as inhibition of parasite development after 24 hrs by qRT-PCR analysis
    [PMID: 24125849]
    HepG2 EC50
    67.6945 3
    Compound: 2
    Antiproliferative activity against human HepG2 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human HepG2 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    HUVEC IC50
    88 3
    Compound: 13
    Cytotoxicity against HUVEC after 24 hrs by MTT assay
    Cytotoxicity against HUVEC after 24 hrs by MTT assay
    [PMID: 17591441]
    HepG2 IC50
    >100 3
    Compound: Genistein
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    [PMID: 26896708]
    Ishikawa IC50
    0.51 3
    Compound: genistein
    Estrogenic activity in human Ishikawa cells assessed as induction of alkaline phosphatase activity after 4 days by para-nitrophenol release assay
    Estrogenic activity in human Ishikawa cells assessed as induction of alkaline phosphatase activity after 4 days by para-nitrophenol release assay
    [PMID: 12502307]
    Hs-578T ED50
    3.5 6
    Compound: 5
    Cytotoxicity against human Hs 578T cells after 6 days by MTT assay
    Cytotoxicity against human Hs 578T cells after 6 days by MTT assay
    [PMID: 12088420]
    K562 IC50
    17.56 3
    Compound: 1
    Growth inhibition of K562 cells by XTT assay after 5 days
    Growth inhibition of K562 cells by XTT assay after 5 days
    [PMID: 17411092]
    Hs746T ED50
    5.82 6
    Compound: 5
    Cytotoxicity against human Hs 746T cells after 6 days by MTT assay
    Cytotoxicity against human Hs 746T cells after 6 days by MTT assay
    [PMID: 12088420]
    KOPN-8 EC50
    > 86.2069 3
    Compound: 2
    Antiproliferative activity against human KOPN8 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human KOPN8 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    HT-29 IC50
    52.78 3
    Compound: 1
    Cytotoxicity against human HT-29 cells after 72 hrs by SRB assay
    Cytotoxicity against human HT-29 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    Caco-2 IC50
    > 100 3
    Compound: 1
    Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay
    Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    L02 IC50
    > 100 3
    Compound: Genistein
    Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
    Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
    [PMID: 26896708]
    HT-29 IC50
    50 3
    Compound: Gen
    Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    Huh-7 CC50
    >50 3
    Compound: 23
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    [PMID: 22445328]
    LN-229 IC50
    44 3
    Compound: Gen
    Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    DLD-1 IC50
    50 3
    Compound: 51
    Antiproliferative activity against human DLD-1 cells assessed as reduction in cell viability by MTS assay
    Antiproliferative activity against human DLD-1 cells assessed as reduction in cell viability by MTS assay
    [PMID: 33445154]
    LNCaP IC50
    24 3
    Compound: Genistein
    Antiproliferative activity against human LNCAP cells after 72 hrs by MTS assay
    Antiproliferative activity against human LNCAP cells after 72 hrs by MTS assay
    [PMID: 29456113]
    Huh-7 EC50
    14.4 3
    Compound: 23
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    [PMID: 22445328]
    LNCaP IC50
    30.65 3
    Compound: 1
    Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay
    Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay
    [PMID: 21129977]
    Huh-7 IC50
    20 3
    Compound: Genistein
    Antiplasmodial activity against liver sporozoite stage of Plasmodium berghei ANKA expressing GFP infected in human HuH7 cells assessed as inhibition of parasite development after 24 hrs by qRT-PCR analysis
    Antiplasmodial activity against liver sporozoite stage of Plasmodium berghei ANKA expressing GFP infected in human HuH7 cells assessed as inhibition of parasite development after 24 hrs by qRT-PCR analysis
    [PMID: 24125849]
    LNCaP IC50
    31.7 3
    Compound: Genistein
    Antiproliferative activity against human LNCAP cells after 72 hrs in presence of enzalutamide by MTS assay
    Antiproliferative activity against human LNCAP cells after 72 hrs in presence of enzalutamide by MTS assay
    [PMID: 29456113]
    HUVEC IC50
    88 3
    Compound: 13
    Cytotoxicity against HUVEC after 24 hrs by MTT assay
    Cytotoxicity against HUVEC after 24 hrs by MTT assay
    [PMID: 17591441]
    LNCaP IC50
    37.4 3
    Compound: Genistein
    Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    [PMID: 26341135]
    Ishikawa IC50
    0.51 3
    Compound: genistein
    Estrogenic activity in human Ishikawa cells assessed as induction of alkaline phosphatase activity after 4 days by para-nitrophenol release assay
    Estrogenic activity in human Ishikawa cells assessed as induction of alkaline phosphatase activity after 4 days by para-nitrophenol release assay
    [PMID: 12502307]
    LNCaP IC50
    65 3
    Compound: Genistein
    Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human LNCap cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 60 mins by fluorescence based method
    Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human LNCap cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 60 mins by fluorescence based method
    [PMID: 30776692]
    K562 IC50
    17.56 3
    Compound: 1
    Growth inhibition of K562 cells by XTT assay after 5 days
    Growth inhibition of K562 cells by XTT assay after 5 days
    [PMID: 17411092]
    LNCaP-Clone-FGC ED50
    25.45 6
    Compound: 5
    Cytotoxicity against human LNCaP-FGC cells after 6 days by MTT assay
    Cytotoxicity against human LNCaP-FGC cells after 6 days by MTT assay
    [PMID: 12088420]
    LoVo IC50
    15.88 3
    Compound: 1
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    [PMID: 21129977]
    KOPN-8 EC50
    >86.2069 3
    Compound: 2
    Antiproliferative activity against human KOPN8 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human KOPN8 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    MCF7 IC50
    > 30 3
    Compound: genistein
    Cytotoxicity against human MCF7 cells after 72 hrs
    Cytotoxicity against human MCF7 cells after 72 hrs
    [PMID: 10075742]
    L02 IC50
    >100 3
    Compound: Genistein
    Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
    Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
    [PMID: 26896708]
    MCF7 IC50
    1 3
    Compound: genistein
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    [PMID: 20813524]
    LN-229 IC50
    44 3
    Compound: Gen
    Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    MCF7 IC50
    26 3
    Compound: genistein
    Inhibition of phorbol ester-induced ornithine decarboxylase in human MCF7 cells after 6 hrs
    Inhibition of phorbol ester-induced ornithine decarboxylase in human MCF7 cells after 6 hrs
    [PMID: 10075742]
    LNCaP IC50
    10 3
    Compound: Genistein
    Antiproliferative activity against human LNCAP cells
    Antiproliferative activity against human LNCAP cells
    [PMID: 29456113]
    MCF7 IC50
    50 1
    Compound: Genistein
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
    [PMID: 33257172]
    LNCaP IC50
    24 3
    Compound: Genistein
    Antiproliferative activity against human LNCAP cells after 72 hrs by MTS assay
    Antiproliferative activity against human LNCAP cells after 72 hrs by MTS assay
    [PMID: 29456113]
    MCF7 IC50
    62.71 3
    Compound: 1
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    DU-145 ED50
    2.39 6
    Compound: 5
    Cytotoxicity against human DU145 cells after 6 days by MTT assay
    Cytotoxicity against human DU145 cells after 6 days by MTT assay
    [PMID: 12088420]
    MCF7 IC50
    8.8 3
    Compound: 28
    Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
    Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
    [PMID: 21354800]
    LNCaP IC50
    31.7 3
    Compound: Genistein
    Antiproliferative activity against human LNCAP cells after 72 hrs in presence of enzalutamide by MTS assay
    Antiproliferative activity against human LNCAP cells after 72 hrs in presence of enzalutamide by MTS assay
    [PMID: 29456113]
    DU-145 IC50
    47.29 3
    Compound: 1
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    LNCaP IC50
    37.4 3
    Compound: Genistein
    Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    [PMID: 26341135]
    MDA-MB-231 IC50
    43 3
    Compound: Gen
    Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    DU-145 IC50
    > 100 3
    Compound: Genistein
    Cytotoxicity against human androgen-independent DU145 cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    Cytotoxicity against human androgen-independent DU145 cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    [PMID: 26341135]
    MDCK IC50
    6.9 3
    Compound: 28
    Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
    Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
    [PMID: 21354800]
    HCT-116 IC50
    34.9 3
    Compound: 1
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    LNCaP IC50
    30.65 3
    Compound: 1
    Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay
    Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay
    [PMID: 21129977]
    Melan-a IC50
    57.83 3
    Compound: 6
    Inhibition of melanin formation in mouse Melan-a cells after 5 days by ELISA
    Inhibition of melanin formation in mouse Melan-a cells after 5 days by ELISA
    [PMID: 20022495]
    MCF7 IC50
    50 1
    Compound: Genistein
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
    [PMID: 33257172]
    NCI-H460 IC50
    47 3
    Compound: Gen
    Cytotoxicity against human NCI-H460 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human NCI-H460 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    LNCaP IC50
    65 3
    Compound: Genistein
    Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human LNCap cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 60 mins by fluorescence based method
    Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human LNCap cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 60 mins by fluorescence based method
    [PMID: 30776692]
    Neutrophil IC50
    0.54 6
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation after 5 mins
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation after 5 mins
    [PMID: 21353775]
    LNCaP-Clone-FGC ED50
    25.45 6
    Compound: 5
    Cytotoxicity against human LNCaP-FGC cells after 6 days by MTT assay
    Cytotoxicity against human LNCaP-FGC cells after 6 days by MTT assay
    [PMID: 12088420]
    Neutrophil IC50
    0.69 3
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced superoxide anion production treated 5 mins before FMLP addition measured after 10 mins
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced superoxide anion production treated 5 mins before FMLP addition measured after 10 mins
    [PMID: 23822585]
    LoVo IC50
    15.88 3
    Compound: 1
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    [PMID: 21129977]
    MCF7 GI50
    10 3
    Compound: 2
    Antiproliferative activity against estrogen receptor expressing human MCF7 cells
    Antiproliferative activity against estrogen receptor expressing human MCF7 cells
    [PMID: 19818612]
    Neutrophil IC50
    1.11 3
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLF/cytochalasin B-induced superoxide anion generation preincubated for 5 mins followed by fMLF addition after priming with CB for 3 mins by spectrophotometric analysis
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLF/cytochalasin B-induced superoxide anion generation preincubated for 5 mins followed by fMLF addition after priming with CB for 3 mins by spectrophotometric analysis
    [PMID: 32359855]
    Neutrophil IC50
    6.99 6
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release after 5 mins
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release after 5 mins
    [PMID: 21353775]
    MCF7 IC50
    11 3
    Compound: genistein
    Anti-proliferative activity against estrogen-responsive human breast cancer cell line MCF-7 in the presence of ER at a 10e-4 uM concentration of estradiol
    Anti-proliferative activity against estrogen-responsive human breast cancer cell line MCF-7 in the presence of ER at a 10e-4 uM concentration of estradiol
    [PMID: 8784443]
    MCF7 IC50
    15.1 3
    Compound: (1a) genistein
    Cytotoxic effect on MCF-7 human breast carcinoma cells
    Cytotoxic effect on MCF-7 human breast carcinoma cells
    [PMID: 8201603]
    PANC-1 IC50
    87 3
    Compound: Gen
    Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    MCF7 IC50
    1 × 10-6 41
    Compound: genistein
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    [PMID: 20813524]
    PC-3 IC50
    50 3
    Compound: Genistein
    Antiproliferative activity against human PC3 cell line by MTT assay
    Antiproliferative activity against human PC3 cell line by MTT assay
    [PMID: 16789737]
    HEK293 IC50
    16.5 3
    Compound: 21
    Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
    Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
    [PMID: 18533708]
    HEK293 IC50
    2.21 3
    Compound: 21
    Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
    Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
    [PMID: 18533708]
    PC-3 IC50
    65.17 3
    Compound: 1
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    MCF7 IC50
    >30 3
    Compound: genistein
    Cytotoxicity against human MCF7 cells after 72 hrs
    Cytotoxicity against human MCF7 cells after 72 hrs
    [PMID: 10075742]
    PC-3 IC50
    68.6 3
    Compound: Genistein
    Cytotoxicity against human androgen-independent PC3 cells assessed as cell cell viability after 3 days by WST-1 cell proliferation assay
    Cytotoxicity against human androgen-independent PC3 cells assessed as cell cell viability after 3 days by WST-1 cell proliferation assay
    [PMID: 26341135]
    HEK293 IC50
    22 3
    Compound: genistein
    Antagonist activity at human recombinant LXRbeta expressed in HEK293 cells by luciferase reporter gene assay
    Antagonist activity at human recombinant LXRbeta expressed in HEK293 cells by luciferase reporter gene assay
    [PMID: 18343126]
    MCF7 IC50
    62.71 3
    Compound: 1
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    MCF7 IC50
    77 3
    Compound: genistein
    Inhibition of 10e-4 uM estradiol induced estrogen receptor positive MCF-7 human breast cancer cell proliferation
    Inhibition of 10e-4 uM estradiol induced estrogen receptor positive MCF-7 human breast cancer cell proliferation
    [PMID: 8784443]
    RAW IC50
    18.1 3
    Compound: genistein
    Inhibition of 1 ug/ml LPS-stimulated TNFalpha accumulation in RAW 264 cells after 24 hrs
    Inhibition of 1 ug/ml LPS-stimulated TNFalpha accumulation in RAW 264 cells after 24 hrs
    [PMID: 17320246]
    HEK293 IC50
    25.12 3
    Compound: Genistein
    Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    RAW264.7 IC50
    > 1 3
    Compound: 19
    Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells pretreated for 1 hr followed by LPS-stimulation and measured after 24 hrs by Griess assay
    Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells pretreated for 1 hr followed by LPS-stimulation and measured after 24 hrs by Griess assay
    [PMID: 29932657]
    MCF7 IC50
    8.8 3
    Compound: 28
    Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
    Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
    [PMID: 21354800]
    HEK293 IC50
    31 3
    Compound: genistein
    Antagonist activity at human recombinant LXRalpha expressed in HEK293 cells by luciferase reporter gene assay
    Antagonist activity at human recombinant LXRalpha expressed in HEK293 cells by luciferase reporter gene assay
    [PMID: 18343126]
    RAW264.7 IC50
    > 50 3
    Compound: 10
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay
    [PMID: 25592708]
    MCF7 IC50
    26 3
    Compound: genistein
    Inhibition of phorbol ester-induced ornithine decarboxylase in human MCF7 cells after 6 hrs
    Inhibition of phorbol ester-induced ornithine decarboxylase in human MCF7 cells after 6 hrs
    [PMID: 10075742]
    HEK293 IC50
    58.18 3
    Compound: Genistein
    Inhibition of Fyn (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of Fyn (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    RAW264.7 IC50
    11.4 3
    Compound: Genistein
    Antiosteoporotic activity in mouse RAW264.7 cells assessed as inhibition of RANKL-induced osteoclast differentiation after 4 to 5 days by TRAP assay
    Antiosteoporotic activity in mouse RAW264.7 cells assessed as inhibition of RANKL-induced osteoclast differentiation after 4 to 5 days by TRAP assay
    [PMID: 28169537]
    HEK293 IC50
    67.99 3
    Compound: Genistein
    Inhibition of Bmx (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of Bmx (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    MDA-MB-231 IC50
    43 3
    Compound: Gen
    Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    RAW264.7 IC50
    19.1 3
    Compound: Genistein
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production treated 2 hrs before LPS challenge measured after 24 hrs by ELISA
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production treated 2 hrs before LPS challenge measured after 24 hrs by ELISA
    [PMID: 21288727]
    HEK293 IC50
    > 100 3
    Compound: Genistein
    Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    Inhibition of Src (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay
    [PMID: 25205190]
    RAW264.7 IC50
    26 3
    Compound: Genistein
    Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production after 24 hrs by Griess reagent
    Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production after 24 hrs by Griess reagent
    [PMID: 20363145]
    RAW264.7 IC50
    26.5 3
    Compound: Genistein
    Inhibition of LPS-induced TNFalpha release in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by enzyme immunoassay
    Inhibition of LPS-induced TNFalpha release in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by enzyme immunoassay
    [PMID: 19278854]
    MDCK IC50
    6.9 3
    Compound: 28
    Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
    Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
    [PMID: 21354800]
    Melan-a IC50
    57.83 3
    Compound: 6
    Inhibition of melanin formation in mouse Melan-a cells after 5 days by ELISA
    Inhibition of melanin formation in mouse Melan-a cells after 5 days by ELISA
    [PMID: 20022495]
    SEM EC50
    59.338 3
    Compound: 2
    Antiproliferative activity against human SEM cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human SEM cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    Sf9 IC50
    > 100 3
    Compound: 10
    Inhibition of His6-tagged human recombinant DNMT3A/DNMT3L expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid
    Inhibition of His6-tagged human recombinant DNMT3A/DNMT3L expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid
    [PMID: 25406944]
    NCI-H460 IC50
    47 3
    Compound: Gen
    Cytotoxicity against human NCI-H460 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human NCI-H460 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    Sf9 IC50
    30 3
    Compound: 10
    Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintil
    Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintil
    [PMID: 25406944]
    Neutrophil IC50
    1.11 3
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLF/cytochalasin B-induced superoxide anion generation preincubated for 5 mins followed by fMLF addition after priming with CB for 3 mins by spectrophotometric analysis
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLF/cytochalasin B-induced superoxide anion generation preincubated for 5 mins followed by fMLF addition after priming with CB for 3 mins by spectrophotometric analysis
    [PMID: 32359855]
    SK-BR-3 EC50
    403 3
    Compound: 2
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    Neutrophil IC50
    6.99 6
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release after 5 mins
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release after 5 mins
    [PMID: 21353775]
    Neutrophil IC50
    0.54 6
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation after 5 mins
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation after 5 mins
    [PMID: 21353775]
    SK-BR-3 IC50
    96.7 3
    Compound: 1
    Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay
    Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    Neutrophil IC50
    6.72 3
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced elastase release treated 5 mins before FMLP addition
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced elastase release treated 5 mins before FMLP addition
    [PMID: 23822585]
    SK-BR-3 EC50
    97 3
    Compound: 2
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    SK-MEL-2 IC50
    36 3
    Compound: Gen
    Cytotoxicity against human SK-MEL-2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human SK-MEL-2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    Neutrophil IC50
    0.69 3
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced superoxide anion production treated 5 mins before FMLP addition measured after 10 mins
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced superoxide anion production treated 5 mins before FMLP addition measured after 10 mins
    [PMID: 23822585]
    SUP-B15 EC50
    > 86.2069 3
    Compound: 2
    Antiproliferative activity against human SUP-B15 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human SUP-B15 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    T47D IC50
    48 3
    Compound: Gen
    Cytotoxicity against human T47D cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human T47D cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    PANC-1 IC50
    87 3
    Compound: Gen
    Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    T98G IC50
    89.41 3
    Compound: 1
    Cytotoxicity against human T98G cells after 72 hrs by SRB assay
    Cytotoxicity against human T98G cells after 72 hrs by SRB assay
    [PMID: 21129977]
    PC-3 IC50
    50 3
    Compound: Genistein
    Antiproliferative activity against human PC3 cell line by MTT assay
    Antiproliferative activity against human PC3 cell line by MTT assay
    [PMID: 16789737]
    U-87MG ATCC IC50
    55 3
    Compound: Gen
    Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    U-937 IC50
    > 100 3
    Compound: 5
    Antiproliferative activity against human U937 cells after 24 hrs by WST-8 assay
    Antiproliferative activity against human U937 cells after 24 hrs by WST-8 assay
    [PMID: 17158054]
    PC-3 IC50
    68.6 3
    Compound: Genistein
    Cytotoxicity against human androgen-independent PC3 cells assessed as cell cell viability after 3 days by WST-1 cell proliferation assay
    Cytotoxicity against human androgen-independent PC3 cells assessed as cell cell viability after 3 days by WST-1 cell proliferation assay
    [PMID: 26341135]
    PC-3 IC50
    65.17 3
    Compound: 1
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    U-937 IC50
    48 3
    Compound: 5
    Antiproliferative activity against human U937 cells after 72 hrs by WST-8 assay
    Antiproliferative activity against human U937 cells after 72 hrs by WST-8 assay
    [PMID: 17158054]
    RAW IC50
    18.1 3
    Compound: genistein
    Inhibition of 1 ug/ml LPS-stimulated TNFalpha accumulation in RAW 264 cells after 24 hrs
    Inhibition of 1 ug/ml LPS-stimulated TNFalpha accumulation in RAW 264 cells after 24 hrs
    [PMID: 17320246]
    U-937 IC50
    72 3
    Compound: 5
    Antiproliferative activity against human U937 cells after 48 hrs by WST-8 assay
    Antiproliferative activity against human U937 cells after 48 hrs by WST-8 assay
    [PMID: 17158054]
    UoC-B1 EC50
    35.6958 3
    Compound: 2
    Antiproliferative activity against human UOCB1 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human UOCB1 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    RAW264.7 IC50
    26 3
    Compound: Genistein
    Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production after 24 hrs by Griess reagent
    Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production after 24 hrs by Griess reagent
    [PMID: 20363145]
    RAW264.7 IC50
    >50 3
    Compound: 10
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay
    [PMID: 25592708]
    Ventricular myocyte IC50
    11 3
    Compound: Genistein
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
    [PMID: 22761000]
    RAW264.7 IC50
    19.1 3
    Compound: Genistein
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production treated 2 hrs before LPS challenge measured after 24 hrs by ELISA
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production treated 2 hrs before LPS challenge measured after 24 hrs by ELISA
    [PMID: 21288727]
    Ventricular myocyte IC50
    20 3
    Compound: Genistein
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
    [PMID: 22761000]
    RAW264.7 IC50
    11.4 3
    Compound: Genistein
    Antiosteoporotic activity in mouse RAW264.7 cells assessed as inhibition of RANKL-induced osteoclast differentiation after 4 to 5 days by TRAP assay
    Antiosteoporotic activity in mouse RAW264.7 cells assessed as inhibition of RANKL-induced osteoclast differentiation after 4 to 5 days by TRAP assay
    [PMID: 28169537]
    RAW264.7 IC50
    >1 3
    Compound: 19
    Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells pretreated for 1 hr followed by LPS-stimulation and measured after 24 hrs by Griess assay
    Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells pretreated for 1 hr followed by LPS-stimulation and measured after 24 hrs by Griess assay
    [PMID: 29932657]
    RAW264.7 IC50
    26.5 3
    Compound: Genistein
    Inhibition of LPS-induced TNFalpha release in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by enzyme immunoassay
    Inhibition of LPS-induced TNFalpha release in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by enzyme immunoassay
    [PMID: 19278854]
    SEM EC50
    59.338 3
    Compound: 2
    Antiproliferative activity against human SEM cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human SEM cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    Sf9 IC50
    30 3
    Compound: 10
    Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintil
    Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintil
    [PMID: 25406944]
    Sf9 IC50
    >100 3
    Compound: 10
    Inhibition of His6-tagged human recombinant DNMT3A/DNMT3L expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid
    Inhibition of His6-tagged human recombinant DNMT3A/DNMT3L expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid
    [PMID: 25406944]
    SK-BR-3 EC50
    403 3
    Compound: 2
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    SK-BR-3 EC50
    97 3
    Compound: 2
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    SK-BR-3 IC50
    96.7 3
    Compound: 1
    Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay
    Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    SK-MEL-2 IC50
    36 3
    Compound: Gen
    Cytotoxicity against human SK-MEL-2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human SK-MEL-2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    SUP-B15 EC50
    >86.2069 3
    Compound: 2
    Antiproliferative activity against human SUP-B15 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human SUP-B15 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    T47D IC50
    48 3
    Compound: Gen
    Cytotoxicity against human T47D cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human T47D cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    T98G IC50
    89.41 3
    Compound: 1
    Cytotoxicity against human T98G cells after 72 hrs by SRB assay
    Cytotoxicity against human T98G cells after 72 hrs by SRB assay
    [PMID: 21129977]
    U-87MG ATCC IC50
    55 3
    Compound: Gen
    Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    U-937 IC50
    >100 3
    Compound: 5
    Antiproliferative activity against human U937 cells after 24 hrs by WST-8 assay
    Antiproliferative activity against human U937 cells after 24 hrs by WST-8 assay
    [PMID: 17158054]
    U-937 IC50
    72 3
    Compound: 5
    Antiproliferative activity against human U937 cells after 48 hrs by WST-8 assay
    Antiproliferative activity against human U937 cells after 48 hrs by WST-8 assay
    [PMID: 17158054]
    U-937 IC50
    48 3
    Compound: 5
    Antiproliferative activity against human U937 cells after 72 hrs by WST-8 assay
    Antiproliferative activity against human U937 cells after 72 hrs by WST-8 assay
    [PMID: 17158054]
    UoC-B1 EC50
    35.6958 3
    Compound: 2
    Antiproliferative activity against human UOCB1 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human UOCB1 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    Ventricular myocyte IC50
    20 3
    Compound: Genistein
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
    [PMID: 22761000]
    HT-29 IC50
    50 3
    Compound: Gen
    Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    HT-29 IC50
    52.78 3
    Compound: 1
    Cytotoxicity against human HT-29 cells after 72 hrs by SRB assay
    Cytotoxicity against human HT-29 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    Ventricular myocyte IC50
    11 3
    Compound: Genistein
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
    [PMID: 22761000]
    HUVEC IC50
    88 3
    Compound: 13
    Cytotoxicity against HUVEC after 24 hrs by MTT assay
    Cytotoxicity against HUVEC after 24 hrs by MTT assay
    [PMID: 17591441]
    HeLa EC50
    4.1 1
    Compound: genistein
    Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta.
    Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta.
    [PMID: 11906280]
    HeLa EC50
    48 1
    Compound: genistein
    Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.
    Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.
    [PMID: 11906280]
    HeLa EC50
    73 1
    Compound: genistein
    Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay
    Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay
    [PMID: 16610787]
    HeLa EC50
    956 1
    Compound: genistein
    Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay at 10 uM
    Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay at 10 uM
    [PMID: 16610787]
    HepG2 EC50
    67.6945 3
    Compound: 2
    Antiproliferative activity against human HepG2 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human HepG2 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    HepG2 IC50
    > 100 3
    Compound: Genistein
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
    [PMID: 26896708]
    Hs-578T ED50
    3.5 6
    Compound: 5
    Cytotoxicity against human Hs 578T cells after 6 days by MTT assay
    Cytotoxicity against human Hs 578T cells after 6 days by MTT assay
    [PMID: 12088420]
    Hs746T ED50
    5.82 6
    Compound: 5
    Cytotoxicity against human Hs 746T cells after 6 days by MTT assay
    Cytotoxicity against human Hs 746T cells after 6 days by MTT assay
    [PMID: 12088420]
    Huh-7 CC50
    > 50 3
    Compound: 23
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    [PMID: 22445328]
    Huh-7 EC50
    14.4 3
    Compound: 23
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    [PMID: 22445328]
    Huh-7 IC50
    20 3
    Compound: Genistein
    Antiplasmodial activity against liver sporozoite stage of Plasmodium berghei ANKA expressing GFP infected in human HuH7 cells assessed as inhibition of parasite development after 24 hrs by qRT-PCR analysis
    Antiplasmodial activity against liver sporozoite stage of Plasmodium berghei ANKA expressing GFP infected in human HuH7 cells assessed as inhibition of parasite development after 24 hrs by qRT-PCR analysis
    [PMID: 24125849]
    Ishikawa IC50
    0.51 3
    Compound: genistein
    Estrogenic activity in human Ishikawa cells assessed as induction of alkaline phosphatase activity after 4 days by para-nitrophenol release assay
    Estrogenic activity in human Ishikawa cells assessed as induction of alkaline phosphatase activity after 4 days by para-nitrophenol release assay
    [PMID: 12502307]
    K562 IC50
    17.56 3
    Compound: 1
    Growth inhibition of K562 cells by XTT assay after 5 days
    Growth inhibition of K562 cells by XTT assay after 5 days
    [PMID: 17411092]
    KB ED50
    6.7 6
    Compound: NSC-36586
    Cytotoxicity against human KB cells
    Cytotoxicity against human KB cells
    [PMID: 469554]
    KOPN-8 EC50
    > 86.2069 3
    Compound: 2
    Antiproliferative activity against human KOPN8 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human KOPN8 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    L02 IC50
    > 100 3
    Compound: Genistein
    Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
    Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
    [PMID: 26896708]
    LN-229 IC50
    44 3
    Compound: Gen
    Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    LNCaP IC50
    10 3
    Compound: Genistein
    Antiproliferative activity against human LNCAP cells
    Antiproliferative activity against human LNCAP cells
    [PMID: 29456113]
    LNCaP IC50
    24 3
    Compound: Genistein
    Antiproliferative activity against human LNCAP cells after 72 hrs by MTS assay
    Antiproliferative activity against human LNCAP cells after 72 hrs by MTS assay
    [PMID: 29456113]
    LNCaP IC50
    30.65 3
    Compound: 1
    Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay
    Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay
    [PMID: 21129977]
    LNCaP IC50
    31.7 3
    Compound: Genistein
    Antiproliferative activity against human LNCAP cells after 72 hrs in presence of enzalutamide by MTS assay
    Antiproliferative activity against human LNCAP cells after 72 hrs in presence of enzalutamide by MTS assay
    [PMID: 29456113]
    LNCaP IC50
    37.4 3
    Compound: Genistein
    Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay
    [PMID: 26341135]
    LNCaP IC50
    65 3
    Compound: Genistein
    Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human LNCap cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 60 mins by fluorescence based method
    Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human LNCap cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 60 mins by fluorescence based method
    [PMID: 30776692]
    LNCaP-Clone-FGC ED50
    25.45 6
    Compound: 5
    Cytotoxicity against human LNCaP-FGC cells after 6 days by MTT assay
    Cytotoxicity against human LNCaP-FGC cells after 6 days by MTT assay
    [PMID: 12088420]
    LoVo IC50
    15.88 3
    Compound: 1
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    [PMID: 21129977]
    MCF7 GI50
    10 3
    Compound: 2
    Antiproliferative activity against estrogen receptor expressing human MCF7 cells
    Antiproliferative activity against estrogen receptor expressing human MCF7 cells
    [PMID: 19818612]
    MCF7 IC50
    1 x 10-6 41
    Compound: genistein
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
    [PMID: 20813524]
    MCF7 IC50
    11 3
    Compound: genistein
    Anti-proliferative activity against estrogen-responsive human breast cancer cell line MCF-7 in the presence of ER at a 10e-4 uM concentration of estradiol
    Anti-proliferative activity against estrogen-responsive human breast cancer cell line MCF-7 in the presence of ER at a 10e-4 uM concentration of estradiol
    [PMID: 8784443]
    MCF7 IC50
    15.1 3
    Compound: (1a) genistein
    Cytotoxic effect on MCF-7 human breast carcinoma cells
    Cytotoxic effect on MCF-7 human breast carcinoma cells
    [PMID: 8201603]
    MCF7 IC50
    26 3
    Compound: genistein
    Inhibition of phorbol ester-induced ornithine decarboxylase in human MCF7 cells after 6 hrs
    Inhibition of phorbol ester-induced ornithine decarboxylase in human MCF7 cells after 6 hrs
    [PMID: 10075742]
    MCF7 IC50
    50 1
    Compound: Genistein
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
    Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
    [PMID: 33257172]
    MCF7 IC50
    62.71 3
    Compound: 1
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    MCF7 IC50
    77 3
    Compound: genistein
    Inhibition of 10e-4 uM estradiol induced estrogen receptor positive MCF-7 human breast cancer cell proliferation
    Inhibition of 10e-4 uM estradiol induced estrogen receptor positive MCF-7 human breast cancer cell proliferation
    [PMID: 8784443]
    MCF7 IC50
    8.8 3
    Compound: 28
    Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
    Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
    [PMID: 21354800]
    MCF7 IC50
    > 30 3
    Compound: genistein
    Cytotoxicity against human MCF7 cells after 72 hrs
    Cytotoxicity against human MCF7 cells after 72 hrs
    [PMID: 10075742]
    MDA-MB-231 IC50
    43 3
    Compound: Gen
    Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    MDA-MB-436 GI50
    17 3
    Compound: 2
    Antiproliferative activity against estrogen receptor expressing human MDA-MB-436 cells
    Antiproliferative activity against estrogen receptor expressing human MDA-MB-436 cells
    [PMID: 19818612]
    MDCK IC50
    6.9 3
    Compound: 28
    Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
    Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
    [PMID: 21354800]
    Melan-a IC50
    57.83 3
    Compound: 6
    Inhibition of melanin formation in mouse Melan-a cells after 5 days by ELISA
    Inhibition of melanin formation in mouse Melan-a cells after 5 days by ELISA
    [PMID: 20022495]
    NCI-H460 IC50
    47 3
    Compound: Gen
    Cytotoxicity against human NCI-H460 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human NCI-H460 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    NIH3T3 EC50
    4.4 3
    Compound: Genistein
    Agonist activity at CFTR-deltaF508 mutant expressed in NIH3T3 cells assessed as increase in forskolin-stimulated current
    Agonist activity at CFTR-deltaF508 mutant expressed in NIH3T3 cells assessed as increase in forskolin-stimulated current
    [PMID: 18595696]
    NIH3T3 IC50
    24 3
    Compound: (1a) genistein
    Cytotoxic effect on 3T3 cells
    Cytotoxic effect on 3T3 cells
    [PMID: 8201603]
    Neutrophil IC50
    0.54 6
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation after 5 mins
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation after 5 mins
    [PMID: 21353775]
    Neutrophil IC50
    0.69 3
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced superoxide anion production treated 5 mins before FMLP addition measured after 10 mins
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced superoxide anion production treated 5 mins before FMLP addition measured after 10 mins
    [PMID: 23822585]
    Neutrophil IC50
    1.11 3
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLF/cytochalasin B-induced superoxide anion generation preincubated for 5 mins followed by fMLF addition after priming with CB for 3 mins by spectrophotometric analysis
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLF/cytochalasin B-induced superoxide anion generation preincubated for 5 mins followed by fMLF addition after priming with CB for 3 mins by spectrophotometric analysis
    [PMID: 32359855]
    Neutrophil IC50
    6.72 3
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced elastase release treated 5 mins before FMLP addition
    Antiinflammatory activity in human neutrophils assessed as inhibition of FMLP-induced elastase release treated 5 mins before FMLP addition
    [PMID: 23822585]
    Neutrophil IC50
    6.99 6
    Compound: Genistein
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release after 5 mins
    Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/CB-induced elastase release after 5 mins
    [PMID: 21353775]
    PANC-1 IC50
    87 3
    Compound: Gen
    Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    PC-3 IC50
    50 3
    Compound: Genistein
    Antiproliferative activity against human PC3 cell line by MTT assay
    Antiproliferative activity against human PC3 cell line by MTT assay
    [PMID: 16789737]
    PC-3 IC50
    65.17 3
    Compound: 1
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    [PMID: 21129977]
    PC-3 IC50
    68.6 3
    Compound: Genistein
    Cytotoxicity against human androgen-independent PC3 cells assessed as cell cell viability after 3 days by WST-1 cell proliferation assay
    Cytotoxicity against human androgen-independent PC3 cells assessed as cell cell viability after 3 days by WST-1 cell proliferation assay
    [PMID: 26341135]
    Peritoneal macrophage IC50
    16.87 3
    Compound: 120
    Antiinflammatory activity against LPS-stimulated mouse peritoneal macrophage assessed as TNF-alpha level
    Antiinflammatory activity against LPS-stimulated mouse peritoneal macrophage assessed as TNF-alpha level
    [PMID: 37683361]
    RAW IC50
    18.1 3
    Compound: genistein
    Inhibition of 1 ug/ml LPS-stimulated TNFalpha accumulation in RAW 264 cells after 24 hrs
    Inhibition of 1 ug/ml LPS-stimulated TNFalpha accumulation in RAW 264 cells after 24 hrs
    [PMID: 17320246]
    RAW264.7 IC50
    11.4 3
    Compound: Genistein
    Antiosteoporotic activity in mouse RAW264.7 cells assessed as inhibition of RANKL-induced osteoclast differentiation after 4 to 5 days by TRAP assay
    Antiosteoporotic activity in mouse RAW264.7 cells assessed as inhibition of RANKL-induced osteoclast differentiation after 4 to 5 days by TRAP assay
    [PMID: 28169537]
    RAW264.7 IC50
    19.1 3
    Compound: Genistein
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production treated 2 hrs before LPS challenge measured after 24 hrs by ELISA
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production treated 2 hrs before LPS challenge measured after 24 hrs by ELISA
    [PMID: 21288727]
    RAW264.7 IC50
    26 3
    Compound: Genistein
    Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production after 24 hrs by Griess reagent
    Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production after 24 hrs by Griess reagent
    [PMID: 20363145]
    RAW264.7 IC50
    26.5 3
    Compound: Genistein
    Inhibition of LPS-induced TNFalpha release in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by enzyme immunoassay
    Inhibition of LPS-induced TNFalpha release in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by enzyme immunoassay
    [PMID: 19278854]
    RAW264.7 IC50
    > 1 3
    Compound: 19
    Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells pretreated for 1 hr followed by LPS-stimulation and measured after 24 hrs by Griess assay
    Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells pretreated for 1 hr followed by LPS-stimulation and measured after 24 hrs by Griess assay
    [PMID: 29932657]
    RAW264.7 IC50
    > 50 3
    Compound: 10
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay
    Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay
    [PMID: 25592708]
    SEM EC50
    59.338 3
    Compound: 2
    Antiproliferative activity against human SEM cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human SEM cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    SH-SY5Y EC50
    1.7 1
    Compound: genistein
    Agonist activity in transcriptional activation assay in SH-SY5Y neuroblastoma cells expressing Estrogen receptor beta
    Agonist activity in transcriptional activation assay in SH-SY5Y neuroblastoma cells expressing Estrogen receptor beta
    [PMID: 11906280]
    SK-BR-3 EC50
    403 3
    Compound: 2
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    SK-BR-3 EC50
    97 3
    Compound: 2
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    Antiproliferative activity against human SKBR3 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay
    [PMID: 24456004]
    SK-BR-3 IC50
    96.7 3
    Compound: 1
    Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay
    Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay
    [PMID: 21129977]
    SK-MEL-2 IC50
    36 3
    Compound: Gen
    Cytotoxicity against human SK-MEL-2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human SK-MEL-2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    SUP-B15 EC50
    > 86.2069 3
    Compound: 2
    Antiproliferative activity against human SUP-B15 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human SUP-B15 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    Sf9 IC50
    30 3
    Compound: 10
    Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintil
    Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintil
    [PMID: 25406944]
    Sf9 IC50
    > 100 3
    Compound: 10
    Inhibition of His6-tagged human recombinant DNMT3A/DNMT3L expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid
    Inhibition of His6-tagged human recombinant DNMT3A/DNMT3L expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid
    [PMID: 25406944]
    T47D IC50
    48 3
    Compound: Gen
    Cytotoxicity against human T47D cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human T47D cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    T98G IC50
    89.41 3
    Compound: 1
    Cytotoxicity against human T98G cells after 72 hrs by SRB assay
    Cytotoxicity against human T98G cells after 72 hrs by SRB assay
    [PMID: 21129977]
    U-87MG ATCC IC50
    55 3
    Compound: Gen
    Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay
    [PMID: 28654265]
    U-937 IC50
    48 3
    Compound: 5
    Antiproliferative activity against human U937 cells after 72 hrs by WST-8 assay
    Antiproliferative activity against human U937 cells after 72 hrs by WST-8 assay
    [PMID: 17158054]
    U-937 IC50
    72 3
    Compound: 5
    Antiproliferative activity against human U937 cells after 48 hrs by WST-8 assay
    Antiproliferative activity against human U937 cells after 48 hrs by WST-8 assay
    [PMID: 17158054]
    U-937 IC50
    > 100 3
    Compound: 5
    Antiproliferative activity against human U937 cells after 24 hrs by WST-8 assay
    Antiproliferative activity against human U937 cells after 24 hrs by WST-8 assay
    [PMID: 17158054]
    UoC-B1 EC50
    35.6958 3
    Compound: 2
    Antiproliferative activity against human UOCB1 cells after 72 hrs by CelTiter-Glo assay
    Antiproliferative activity against human UOCB1 cells after 72 hrs by CelTiter-Glo assay
    [PMID: 29407975]
    Ventricular myocyte IC50
    11 3
    Compound: Genistein
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
    [PMID: 22761000]
    Ventricular myocyte IC50
    20 3
    Compound: Genistein
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
    Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
    [PMID: 22761000]
    Vero CC50
    > 50 3
    Compound: 64
    Cytotoxicity against african green monkey Vero cells
    Cytotoxicity against african green monkey Vero cells
    [PMID: 33539089]
    Vero IC50
    32.9 3
    Compound: Genistein
    Cytotoxicity against african green monkey Vero cells
    Cytotoxicity against african green monkey Vero cells
    [PMID: 16441066]
    WiDr IC50
    27.7 3
    Compound: (1a) genistein
    Cytotoxic effect on WiDr human colon cells
    Cytotoxic effect on WiDr human colon cells
    [PMID: 8201603]
    体外実験

    Genistein inhibits serum-stimulated growth of MCF-7 and T47D ER+ cells with IC50 values of 7.6 and 8.7 μg/mL by dye exclusion, respectively, and 8.7 and 10.6 μg/mL by [3H]thymidmne incorporation, respectively. These values are similar to the IC50 values of 9.4 and 7 μg/mL for MCF-7 and T47D ER+ cells, respectively, obtained with the MTT assay. Additionally, Genistein at concentrations up to 20 μg/mL does not alter MTT mitochondrial reduction when compared to control cells in an 8 h incubation period. Furthermore, neither biochanin A or daidzein are found to interfere with the MTT assay at IC50 concentrations. Therefore, the MTT assay is valid for determining growth inhibition by Genistein at concentrations under 20 μg/mL in the systems studied[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    体内実験

    Bisphenol A (BPA) treatment alone and combined with Genistein had no significant effect on the protein expression of LC3II and PPARα in liver of STD- or HFD-fed rats (P>0.05; P>0.05). Significant decreasing of the protein expression of PPARγ in liver is observed when Genistein is added to rats, compared to either HFD group or HFD-BPA group[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    臨床実験
    分子量

    270.24

    分子式

    C15H10O5

    CAS 番号
    Appearance

    Solid

    Color

    White to yellow

    SMILES

    OC1=C2C(OC=C(C3=CC=C(O)C=C3)C2=O)=CC(O)=C1

    Structure Classification
    Initial Source
    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : ≥ 100 mg/mL (370.04 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : < 0.1 mg/mL (insoluble)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.7004 mL 18.5021 mL 37.0041 mL
    5 mM 0.7401 mL 3.7004 mL 7.4008 mL
    10 mM 0.3700 mL 1.8502 mL 3.7004 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 3.75 mg/mL (13.88 mM); Clear solution

      This protocol yields a clear solution of ≥ 3.75 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (37.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 3 mg/mL (11.10 mM); Clear solution

      This protocol yields a clear solution of ≥ 3 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (30.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  50% PEG300    50% Saline

      Solubility: 5 mg/mL (18.50 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション

    純度: 99.82%

    参考文献
    細胞実験
    [1]

    The IC50 values for Genistein are determined by the MTT assay. Briefly, the MTT assay is a colorimetric assay that is based on the ability of living but not dead cells to reduce a tetrazolium-based compound to a blue formazan product. The formazan crystals are solubilized in DMSO, and the absorbance is measured at 540 nm. The absorbance at 540 nm is proportional to the number of viable cells. The lC50 values obtained with the MTT assay are compared with the lC50 values obtained by counting viable cells using trypan blue dye exclusion and by tritiated thymidine incorporation into DNA[1].

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。

    動物実験
    [2][3]

    Mice[2]
    Balb/c male mice are used. Genistein is administered as follows: On days 1-30, Genistein once daily, interaperitoneally injecting. Morphine plus Genistein is administered as follows: On days 1-30, Genistein once daily plus morphine, interaperitoneally injecting (17, 18). The same volume of saline is administered. Mice are randomly divided into 8 groups (n=6). 1) Normal saline group (1 mL DW/daily); 2) Morphine treated group; 3) Genistein 1 mg/kg treated group; 4) Genistein 2 mg/kg treated group 5) Genistein 4 mg/kg treated group; 6) Morphine plus Genistein 1 mg/kg treated group; 7) Morphine plus Genistein 2 mg/kg treated group; 8) Morphine plus Genistein 4 mg/kg treated group.
    Rats[3]
    Male 8-week-old Wistar rats (150-180g) are used. After one week acclimation, all rats are randomly divided into 8 groups with 10 rats per group and treated for 35 weeks as follows: (1) STD group is fed with rodent standard chow diet (STD); (2) STD-BPA group is fed with STD and administered with BPA (50 μg/kg/day); (3) STD-(BPA+G) group is fed with STD and administered with BPA (50 μg/kg/day) plus Genistein (10 mg/kg/day); (4) STD-G group is fed with STD and administered with Genistein (10 mg/kg/day); (5) HFD group received high-fat diet (HFD); (6) HFD-BPA group is fed with HFD and administered with BPA (50 μg/kg/day); (7) STD-(BPA+G) group is fed with HFD and administered with BPA (50 μg/kg/day) plus Genistein (10 mg/kg/day); (8) HFD-G group is fed with HFD and administrated with Genistein (10 mg/kg/day). All the male genitors are treated for 35 weeks consecutively. The details of BPA (50 μg/kg/day) and Genistein (10 mg/kg/day) treatment methods have been described previously: BPA is dissolved in corn oil and diluted with three stock solutions (20, 40, 80, and 120 μg/mL).

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.7004 mL 18.5021 mL 37.0041 mL 92.5104 mL
    5 mM 0.7401 mL 3.7004 mL 7.4008 mL 18.5021 mL
    10 mM 0.3700 mL 1.8502 mL 3.7004 mL 9.2510 mL
    15 mM 0.2467 mL 1.2335 mL 2.4669 mL 6.1674 mL
    20 mM 0.1850 mL 0.9251 mL 1.8502 mL 4.6255 mL
    25 mM 0.1480 mL 0.7401 mL 1.4802 mL 3.7004 mL
    30 mM 0.1233 mL 0.6167 mL 1.2335 mL 3.0837 mL
    40 mM 0.0925 mL 0.4626 mL 0.9251 mL 2.3128 mL
    50 mM 0.0740 mL 0.3700 mL 0.7401 mL 1.8502 mL
    60 mM 0.0617 mL 0.3084 mL 0.6167 mL 1.5418 mL
    80 mM 0.0463 mL 0.2313 mL 0.4626 mL 1.1564 mL
    100 mM 0.0370 mL 0.1850 mL 0.3700 mL 0.9251 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Genistein
    製品番号:
    HY-14596
    数量:
    MCE 日本正規代理店: